• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Merck

Merck

Merck & Co Inc MRK 3 Star

Last Price$58.12Day Change (%)0.01%
Open Price$58.32Day Change ($)0.00
Day Range57.92–58.4952-Week Range44.62–59.84

As of Thu 07/24/2014 01:48 PM EST | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. Merck Announces Fourth-Quarter 2014 Dividend

    Merck Announces Fourth-Quarter 2014 Dividend

  2. Ligand Partner SAGE Therapeutics Receives Fast Track Designation for Captisol-enabled SAGE-547 to Treat Status Epilepticus

    Ligand Partner SAGE Therapeutics Receives Fast Track Designation for Captisol-enabled SAGE-547 to Treat Status Epilepticus

  3. Research and Markets: Cancer Immunotherapy Market & Clinical Pipeline Insight 2014

    Research and Markets: Cancer Immunotherapy Market & Clinical Pipeline Insight 2014

  4. Research and Markets: World Market for Biosimilars (EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs, Others) 2013-2017

    Research and Markets: World Market for Biosimilars (EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs, Others) 2013-2017

  5. Research and Markets: Global Animal (Companion & Production) Healthcare Market 2014-2019 Featuring Key Companies, Zoetis, Merck , Merial, Bayer and Novartis

    Research and Markets: Global Animal (Companion & Production) Healthcare Market 2014-2019 Featuring Key Companies, Zoetis, Merck , Merial, Bayer and Novartis

  6. VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman

    VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman

  7. Have Emerging Markets Gotten Oversold?

    Merck MRK announced Tuesday that Januvia for Type 2 diabetes received Food and Drug Administration approval. While we think Januvia is an important advance in diabetes treatment, we're not changing our fair value estimate for Merck , as we had already incorporated sales from the drug into our model. ...

  8. Merck KGaA Launch of compulsory acquisition procedure

    Merck KGaA Launch of compulsory acquisition procedure

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.